DSpace logo

Please use this identifier to cite or link to this item: http://142.54.178.187:9060/xmlui/handle/123456789/16644
Full metadata record
DC FieldValueLanguage
dc.contributor.authorI Ahmad-
dc.contributor.authorW Hussain-
dc.date.accessioned2023-01-23T09:50:54Z-
dc.date.available2023-01-23T09:50:54Z-
dc.date.issued1993-01-08-
dc.identifier.citationAhmad, I., & Hussain, W. (1993). Stability of cyanocobalamin in parenteral preparations. Pakistan Journal of Pharmaceutical Sciences, 6(1), 53-59.en_US
dc.identifier.issn1011-601X-
dc.identifier.urihttp://142.54.178.187:9060/xmlui/handle/123456789/16644-
dc.description.abstractThe stability of seven commercial parenteral preparations of cyanocobalamin (vitamin B(12)) on storage under normal laboratory conditions for a period of twelve months has been studied using a two component spectrophotometric method for the simultaneous determination of cyanocobalamin and the degradation product, hydroxocobalamin, at 550 and 525 nm. The single ingredient vitamin B(12) preparations have been found to be stable and the potency lies within the B.P. limits. In multi-ingredient (B(1) + B(6) + B(12)) preparations cyanocobalamin is unstable and degrades from 28% to 37% with concomitant formation of hydroxocobalamin (1.7% to 25.5%) and oxidation products amounting to 56.4% +/- 9.3. Thus more than half of the vitamin content is lost during storage and these preparations are not suitable for parenteral use.en_US
dc.language.isoenen_US
dc.publisherKarachi: Faculty of Pharmacy & Pharmaceutical Sciences University of Karachien_US
dc.titleStability of cyanocobalamin in parenteral preparationsen_US
dc.typeArticleen_US
Appears in Collections:Issue No. 1

Files in This Item:
File Description SizeFormat 
FULL TEXT.pdf130.91 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.